Portfolio company
Houdini Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Houdini Bio provides an AI-powered DNA design platform to help pharmaceutical companies develop genetic medicines that evade cellular silencing for improved durability and safety.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
ZipBio
The company develops artificial intelligence to design gene therapies for pharmaceutical firms and biotechnology researchers.
Dyno Therapeutics
The company designs adeno-associated virus vectors for gene delivery using artificial intelligence for biopharmaceutical and pharmaceutical partners.
Nanograb
This company develops an artificial intelligence platform to design targeted gene delivery vectors and nanoparticles for pharmaceutical organisations developing genetic medicines.
Cassidy Bio
This company develops an AI foundation model to design gene editing therapies and prediction tools for pharmaceutical partners and researchers.
expressionedits
This company develops a computational platform using artificial intelligence to optimise gene design and enhance protein production for biotechnology and pharmaceutical organisations.
DeepSeq.AI
DeepSeq.AI develops an artificial intelligence platform for protein drug discovery and biologics design for pharmaceutical and biotechnology companies.
Undecimal Bio
This company develops targeted siRNA delivery molecules for pharmaceutical partners to treat renovascular diseases using an AI-enabled screening platform.
Form Bio
This company provides a software platform using artificial intelligence to help biopharmaceutical organisations and researchers design and optimise cell and gene therapies.
